[
  {
    "ts": null,
    "headline": "Alphabet and 9 More Stocks to Buy for 2025",
    "summary": "The list reflects a bet that value-oriented investing isn’t completely dead—and that the Magnificent Seven will be less dominant next year.",
    "url": "https://finnhub.io/api/news?id=e4b12a5b760ba7e0ff39a91efe228230f4fea44ff50394f24559ecc2a843813a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734110640,
      "headline": "Alphabet and 9 More Stocks to Buy for 2025",
      "id": 131969347,
      "image": "",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The list reflects a bet that value-oriented investing isn’t completely dead—and that the Magnificent Seven will be less dominant next year.",
      "url": "https://finnhub.io/api/news?id=e4b12a5b760ba7e0ff39a91efe228230f4fea44ff50394f24559ecc2a843813a"
    }
  },
  {
    "ts": null,
    "headline": "Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe?",
    "summary": "Palantir and bitcoin play MicroStrategy are expected to get a Nasdaq 100 index invite Friday. Will Moderna and Super Micro get the axe in the annual rebalancing?",
    "url": "https://finnhub.io/api/news?id=7b39cbb905ed128ce8d0e47c03a8238423db7044031542afaa5bc9c60bb5e437",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734102159,
      "headline": "Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe?",
      "id": 131966442,
      "image": "https://media.zenfs.com/en/ibd.com/0630ea20c662bc66a65d0e392c6d435b",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Palantir and bitcoin play MicroStrategy are expected to get a Nasdaq 100 index invite Friday. Will Moderna and Super Micro get the axe in the annual rebalancing?",
      "url": "https://finnhub.io/api/news?id=7b39cbb905ed128ce8d0e47c03a8238423db7044031542afaa5bc9c60bb5e437"
    }
  },
  {
    "ts": null,
    "headline": "Is Moderna Stock A Sell In December 2024 With Deep Losses Projected For The Fourth Quarter?",
    "summary": "Moderna stock remains under pressure with analysts projecting steep losses in the fourth quarter. Is MRNA stock a sell in December 2024?",
    "url": "https://finnhub.io/api/news?id=57208c156915846047039d45da407d528649754c07b676d2fbd40c1f15d5017d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734101756,
      "headline": "Is Moderna Stock A Sell In December 2024 With Deep Losses Projected For The Fourth Quarter?",
      "id": 131967734,
      "image": "",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna stock remains under pressure with analysts projecting steep losses in the fourth quarter. Is MRNA stock a sell in December 2024?",
      "url": "https://finnhub.io/api/news?id=57208c156915846047039d45da407d528649754c07b676d2fbd40c1f15d5017d"
    }
  },
  {
    "ts": null,
    "headline": "The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind",
    "summary": "In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely to thrive the uncharted waters that were rising all around us. The early winners won big — the WFH plays like Zoom and Peloton and Home Depot, and, of course, the vaccine makers like Pfizer and Moderna.",
    "url": "https://finnhub.io/api/news?id=6da0597daf1ee262d0b838862fd0feaba476b4ce35223e04413bb0c12eadf3d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734084045,
      "headline": "The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind",
      "id": 131967735,
      "image": "https://media.cnn.com/api/v1/images/stellar/prod/gettyimages-1231124292.jpg?c=16x9&q=w_800,c_fill",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely to thrive the uncharted waters that were rising all around us. The early winners won big — the WFH plays like Zoom and Peloton and Home Depot, and, of course, the vaccine makers like Pfizer and Moderna.",
      "url": "https://finnhub.io/api/news?id=6da0597daf1ee262d0b838862fd0feaba476b4ce35223e04413bb0c12eadf3d3"
    }
  }
]